FDA approves lenacapavir as a twice-a-year shot to prevent HIV | AP News
It’s the first step in an anticipated global rollout that could protect millions – although it’s unclear how many in the U.S. and abroad will get access to the powerful new option. (AP video by Lekan Oyekanmi/AP produced by Javier Arciga) This photo provided by Gilead Sciences shows a vial of the company’s HIV prevention medication, Yeztugo, (lenacapvir) at a manufacturing facility in La Verne, Calif., in June 2025. (Gilead Sciences via AP) This photo provided by Gilead Sciences shows packaging for the company’s HIV prevention medication, Yeztugo, (lenacapvir) at a manufacturing facility in La Verne, Calif., in June 2025. (Gilead Sciences via AP) This photo provided by Gilead Sciences shows packaging for the company’s HIV prevention medication, Yeztugo, (lenacapvir) at a manufacturing facility in La Verne, Calif., in June 2025. (Gilead Sciences via AP) A pharmacist holds a vial of lenacapavir, an injectable HIV prevention drug, at the Desmond Tutu Health Foundation’s Masiphumelele Rese
FDA approves lenacapavir as a twice-a-year shot to prevent HIV | AP News Menu World SECTIONS Iran war Russia-Ukraine war Español China Asia Pacific Latin America Europe Africa TOP STORIES Adolf Hitler’s birthplace in Austria reopens as a police station to deter Nazi pilgrimages How protests over a popular minister's firing sparked Ukraine's sudden military reset A protest movement is challenging India's establishment. What to know about the 'Cockroaches' Newsletters The Afternoon Wire Our personalization engine sends you what you may have missed throughout the day. The Morning Wire Our flagshi
related reading
- Hard Drugs | Lenacapavir: The miracle drug that could end AIDSharddrugs.worksinprogress.co
- New HIV Frontier: The Fight To Access Long-Acting Prevention Drugs - Health Policy Watchhealthpolicy-watch.news
- New HIV vaccine shows unprecedented success in preclinical study – lji.orglji.org
- Zidovudine - Wikipediaen.wikipedia.org
- Medical breakthroughs in 2025 - by Saloni Dattaniscientificdiscovery.dev
- mRNA vaccines for HIV trigger strong immune response in peoplenature.com
- Treatment of HIV-associated primary CNS lymphoma with antiretroviral therapy, rituximab, and high-dose methotrexatencbi.nlm.nih.gov
- Popular weight-loss drugs Ozempic and Wegovy may slow biological agingsciencedaily.com
- Press Release: Sanofi’s venglustat accepted for priority review in the US to treat type 3 Gaucher diseasesanofi.com
- How antiviral pill molnupiravir shot ahead in the COVID drug huntnature.com
- How To Save Twenty Million Lives, with Dr. Mark Dybulstatecraft.pub
- The Ozempocalypse Is Nigh - by Scott Alexanderastralcodexten.com